However, the realm of therapeutic approaches targeting Notch signaling is rapidly evolving, offering potential novel methods such as focusing on DLL4–NOTCH1 interactions or exploring combination therapies to effectively impact the Notch pathway in CLL [37]. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.